[Hematologic indices as an available tool in the diagnosis of adverse course of COVID-19]

V I Podzolkov1, E V Volchkova1, A E Pokrovskaya1

  • 1Sechenov First Moscow State Medical University (Sechenov University).

Terapevticheskii Arkhiv
|December 28, 2024
PubMed

Insights

Hematologic ratios like neutrophils/lymphocytes (N/L) and platelets/lymphocytes (P/L) correlate with COVID-19 severity and endothelial dysfunction. These indices, along with lymphocytes/C-reactive protein (L/CRP), can predict cytokine storm development in patients.

Area of Science:

  • Hematology
  • Infectious Diseases
  • Immunology

Context:

  • COVID-19 presents with a wide spectrum of clinical severity.
  • Hematologic parameters are increasingly recognized as potential biomarkers in infectious diseases.
  • Endothelial dysfunction is a key feature of severe COVID-19.

Purpose:

  • To investigate the prognostic value of neutrophils/lymphocytes (N/L), platelets/lymphocytes (P/L), and lymphocytes/C-reactive protein (L/CRP) ratios in COVID-19.
  • To assess the correlation of these hematologic indices with COVID-19 severity and sVCAM-1, a marker of endothelial dysfunction.
  • To determine the predictive capability of these ratios for cytokine storm development.

Summary:

  • 103 COVID-19 patients were stratified into three groups based on CT scan findings.
  • Elevated N/L and P/L ratios were observed in patients with more severe lung involvement (CT group 3).
  • L/CRP ratios decreased with increasing lung lesion severity, while sVCAM-1 levels were higher in groups with greater lung damage.

Impact:

  • Hematologic indices (N/L, P/L, L/CRP) are significantly correlated with COVID-19 severity markers.
  • P/L and L/CRP indices show an association with sVCAM-1, indicating their role in endothelial dysfunction.
  • N/L > 2.53 and L/CRP ≤ 0.043 are identified as predictors for cytokine storm in COVID-19 patients.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
37
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
63
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K